Now, the growing buzz around the use of GLP-1 medications like Ozempic to treat alcohol use disorder finally has new clinical ...

"Anti-vaccine rhetoric is a threat to global health," said biomedical scientist Andrea C. Love, PhD, emphasizing how ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

US sweet protein startup Oobli has raised $18M and partnered with global ingredients giant Ingredion to develop ...

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

Dr Pandey shares key insights on dosing, monitoring, and patient education to sustain therapy and improve outcomes. Essential for cardiologists and PCPs!

If you’ve been using a GLP-1 such as semaglutide, then you’ve likely experienced the powerful effects of this weight loss ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Dr. Len Yaffe, Kessef Capital, joins 'Fast Money' to talk the impact of RFK Jr. on the healthcare industry. Explore the world’s oceans like never before with the Manta Ray, DARPA's cutting-edge ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...